Apollo Health Ventures is a transatlantic early stage Venture Capital firm actively co-founding and investing in transformative healthcare companies targeting age-related diseases and aging itself.

Apollo Health Ventures

Meet us at the Global Healthspan Summit by Hevolution Foundation from November 29th – 30th. Our Co-Founder and Venture Partner Alexandra Sharon Bause will be speaking on two panels this year:

“Follow the Money – Investment for Positive Impact” on Wednesday with Jorge Conde (Andreessen Horowitz), Dr. Andrew Levin (RA Capital Management), Kush Parmar, M.D., Ph.D. (5AM Ventures), and Dr. Christoph Westphal (Longwood Fund). The Panel will be moderated by Dr. Jens Eckstein and Dr. Yury Kukushkin, whom we will share the stage with again the following day.

“Crossing the Valley of Death – Easing the Journey to Market and Long-Term ROI” on Thursday alongside Dr. Matthias Evers (Evotec), Dr. Francisco Leon (Sanofi), Dr. Andrew Levin (RA Capital Management), Matt von Zirkelbach (Eli Lilly and Company), and Dr. Yury Kukushkin (Hevolution Foundation).

Let us know if you want to meet up in Riyadh or email us at info@apollo.vc

#GlobalHealthspanSummit #ApolloVC #Healthspan #Longevity #LifescienceVC #VentureCapital

Meet us this week in Munich at the Bio Europe from November 6th – 8th. Our Partners Dr. Marianne Mertens and Jan Adams will attend the industry's largest gathering of biopharma professionals in Europe, organized by the EBD Group.

Reach out if you are in town or let us know via email: info@apollo.vc
 
#BIOEurope #ApolloVC #Healthspan #Longevity #LifescienceVC #VentureCapital

In Britain, Our Future Health UK is conducting the world’s largest health research study with volunteers to help future generations live in good health for longer. Read the article in The Economist here: https://lnkd.in/dpwU2U-N
 
Milken Institute’s Rajiv Ahuja, JD reflects on the 2022 MEA Summit with one of his discussions centered on the science of longevity that was moderated by our team member Alexandra Sharon Bause. During the discussion, a recurring theme was how aging research is underfunded despite being the top risk factor for chronic diseases. Read all about it in Longevity.Technology: https://lnkd.in/ebkHfEW9
 
An article in Cell Press introduces TEMPO, an innovative approach that combines microvolume liquid-biopsy proteomics, single-cell transcriptomics, and artificial intelligence, has provided insights into the connections between age-related diseases, such as Parkinson’s, and individual cellular aging: https://lnkd.in/e53m_77y
 
Christopher Reyes, PhD and Eyram Adjogatse from our portfolio company Bloom Science, Inc. discuss what the gut-brain axis is and how this intricate connection can revolutionize our understanding and treatment of neurological disorders on Vibe Bio’s Podcast: https://lnkd.in/gm4XUvfH
 
#ICYDK #ApolloVC #Lifespan #Healthspan #Longevity #VentureCapital

Meet us in London at the Investival Showcase created by LSX - partnering for Life Science eXecutives on November 13th. Our Partner Dr. Marianne Mertens will be on the panel “Unlocking Success: A Strategic Guide For Early Stage Biotechs To Attract Investors” alongside Olga Danilchanka (@MRL Ventures Fund at Merck), Thijs Cohen Tervaert (Inkef), and Daniela Begolo (EQT Life Sciences). 

Reach out to Dr. Marianne Mertens if you are in town or let us know via email: info@apollo.vc
 
#Investival #ApolloVC #Healthspan #Longevity #LifescienceVC #VentureCapital

Our portfolio company HAYA Therapeutics has made it to HolonIQ’s annual list of the 200 most promising Health Tech startups in Europe from digital health, biotech, medtech, and other areas where entrepreneurs are driving healthcare innovation. 

We are proud to be part of their journey in developing RNA therapies by leveraging the power of the dark genome.

Find out more here: https://lnkd.in/evWGrEpG

#ApolloVC #Healthspan #Lifespan #Longevity #VentureCapital

Apollo Health Ventures is a transatlantic early stage Venture Capital firm actively co-founding and investing in transformative healthcare companies targeting age-related diseases and aging itself. They leverage potential by combining traditional funding with venture building, acquiring founder shares at nominal value. They also identify and invest in best-in-class companies at an early stage.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general
news daily refresh	general	Aug 6, 2024 11:20 PM	2c50d88a
news processing daily refresh	general	May 20, 2024 3:48 PM	9d2cf1b0
news impact assignment daily	general	May 21, 2024 1:36 PM	bbbc1787
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Nov 30, 2023 2:38 PM	c58dd2a8
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings	Feb 12, 2024 3:26 PM	22a50d6b
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

VC:APOLLO

Apollo Health Ventures